Misplaced Pages

Revision as of 14:27, 26 October 2024

This is the talk page for discussing improvements to the Beta blocker article. This is not a forum for general discussion of the article's subject.

Put new text under old text. Click here to start a new topic. New to Misplaced Pages? Welcome! Learn to edit; get help. Assume good faith Be polite and avoid personal attacks Be welcoming to newcomers Seek dispute resolution if needed Article policies Neutral point of view No original research Verifiability

Find sources: Google (books · news · scholar · free images · WP refs) · FENS · JSTOR · TWL

Archives: 1Auto-archiving period: 2 months

This article is rated C-class on Misplaced Pages's content assessment scale. It is of interest to the following WikiProjects:

Pharmacology Top‑importance This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Misplaced Pages. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology Top This article has been rated as Top-importance on the project's importance scale.

Ideal sources for Misplaced Pages's health content are defined in the guideline Misplaced Pages:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Beta blocker. PubMed provides review articles from the past five years (limit to free review articles) The TRIP database provides clinical publications about evidence-based medicine. Other potential sources include: Centre for Reviews and Dissemination and CDC

The Wikimedia Foundation's Terms of Use require that editors disclose their "employer, client, and affiliation" with respect to any paid contribution; see WP:PAID. For advice about reviewing paid contributions, see WP:COIRESPONSE. Cglife.trummler (talk · contribs) has been paid by CG Life on behalf of Impact Journals.

.

Hyperthyroidism

I removed hyperthyroidism from the list of contraindications because the source doesn't list it as a contraindication for beta blockers; it says that it can exacerbate hyperthyroid symptoms if discontinued abruptly. Hyperthyroidism is also listed as an indication for beta blockers earlier in the article, so it's contradicting itself.

I also removed the sentence claiming that beta blockers should be used with caution because "tachycardia is a useful monitoring parameter in thyroid disease" because it was uncited and I doubt it's possible to find a citation for this. I'm not sure what kind of doctor would be ok with not treating a patient's abnormally high heart rate because it's a (not very precise) indicator that their thyroid levels are abnormal.

I left the line about abrupt withdrawal possibly causing a thyroid storm because that is in the propanolol document (and added the citation that wasn't there), but it doesn't contraindicate the use of beta blockers to treat hyperthyroidism and shouldn't be in that section. I'm just not sure how to fit it into the Adverse Effects section smoothly. I'm also not sure if it should even be included in the article, since I assume hyperthyroidism is not the only condition for which suddenly stopping beta blockers can be potentially dangerous, but it's the only disorder for which it's mentioned. (And if we're being pedantic, that citation is only for propanolol and not for other beta blockers.)

• C-Class pharmacology articles
• Top-importance pharmacology articles
• WikiProject Pharmacology articles
• Talk pages of subject pages with paid contributions